Medical disclaimer
Read this as evidence, not instruction
Background reading, not medical advice. MomMetabolic summarizes published research and FDA labeling for mothers weighing GLP-1 care. It cannot diagnose you, cannot account for your history or hormones, and is no substitute for a licensed clinician who can. Decisions to begin, adjust, pause, or stop any medication belong with your own prescriber.
What this site is
MomMetabolic gathers what the published research and FDA labeling say about GLP-1 care and frames it for mothers. It is a way to walk into a clinician conversation better informed — not a diagnosis, a treatment plan, or a reason to start or stop a medication on your own. Your history, hormones, and goals are specific to you; only a clinician who knows them can advise you.
The mother-specific cautions
GLP-1 medicines are not used in pregnancy or while trying to conceive, and the timing differs by drug: the semaglutide label asks you to stop at least two months before a planned pregnancy, while the tirzepatide label sets no pre-pregnancy window and instead says to stop once a pregnancy is recognized. Tirzepatide can also reduce the efficacy of oral hormonal contraceptives for four weeks after starting and after each dose increase; the semaglutide label carries no contraceptive instruction at all. If you are pregnant, breastfeeding, planning a pregnancy, or managing PCOS, thyroid, or other hormonal conditions, raise all of it with your clinician before acting on anything you read here.
On compounded products
Compounded GLP-1 medications are not FDA-approved finished drug products. Whatever you are considering, take any questions about a medical condition or treatment to a qualified healthcare professional first.